[EN] NUCLEAR TRANSPORT MODULATORS AND USES THEREOF<br/>[FR] MODULATEURS DU TRANSPORT NUCLÉAIRE ET LEURS UTILISATIONS
申请人:KARYOPHARM THERAPEUTICS INC
公开号:WO2013170068A2
公开(公告)日:2013-11-14
The present invention relates to compounds of formula I: and pharmaceutically acceptable salts thereof, pharmaceutical compositions comprising the compounds of formula I, and methods of using said compounds, salts and compositions in the treatment of various disorders associated with CRM1 activity.